NCT07557563Recruiting
Flexible Ureterorenoscopy for Surveillance of Upper Tract Urothelial Carcinoma
Flexible Ureterorenoscopy for Surveillance of Upper Tract Urothelial Carcinoma - A Pilot Study
Source: ClinicalTrials.gov · Last updated 27 Oct 2026
Brief summary (registry, in English)
It is a prospective single-arm pilot study to investigate the safety and feasibility of flexible ureteroscopy under local anaesthesia.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- First submitted
- 22 Apr 2026
- Start date
- 1 Oct 2025
- Primary completion date
- 31 Dec 2027
- Lead sponsor
- Chinese University of Hong Kong
- Diseases
- Bladder cancer
- NCT number
- NCT07557563
What you commit to
- Study type: Interventional
- Planned participants: 10
- From 1 Oct 2025 to the primary completion date, 31 Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Allergy to transurethral lidocaine jelly
Lab values
- On anticoagulation or anti-platelet medication with contraindications for cessation prior to the procedure
Other
- Structural abnormalities in the upper urinary tract on the intended side of examination
Who the study is looking for
- Aged 18 years or older
- Capable of giving informed consent
- Having undergone an kidney-sparing surgery (endoscopic operation or segmental ureterectomy)
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Prince of Wales Hospital Coordinator of this site? Confirm its status | Hong Kong | Hong Kong SAR China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.